BioMarin Pharmaceutical Inc. (BIT:1BMRN)
Italy · Delayed Price · Currency is EUR 45.28
0.00 (0.00%)
At close: Oct 31, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €8.92 billion as of November 3, 2025. Its market cap has decreased by -27.34% in one year.
Market Cap
8.92B
Enterprise Value
8.17B
Revenue
2.64B
Ranking
n/a
PE Ratio
20.12
Stock Price
€45.28
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 8.92B, an increase of 1,996.42%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 8.92B | -26.26% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | 13.01B | -3.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 99.74B |
| Intesa Sanpaolo | 96.13B |
| Enel SpA | 89.08B |
| Ferrari | 61.55B |
| Assicurazioni Generali | 50.64B |
| Eni S.p.A. | 48.36B |
| Leonardo S.p.a. | 29.33B |
| Poste Italiane | 27.03B |